Bloodwise: call for project applications; Risk and prevention research grants; Breast Cancer Now at the EU Oncology Convention; Early Diagnosis Conference: programme announcement; Grant call: childhood and young person cancer causes and prevention; New funding scheme supporting clinical research capacity
“NCRI’s CTRad provided invaluable advice and support during the development of PATHOS. Input from experienced clinical trialists, statisticians, funders and patient representatives helped improve the study design and refine endpoints which made a major contribution to its successful funding application.” Prof. Mererid Evans, Consultant Clinical Oncologist and co-Chief investigator of the PATHOS study.
PATHOS is a […]
“NCRI’s ‘Centres of Excellence’ exercise brought the research community together to define internationally relevant criteria for measuring multidisciplinary radiotherapy research activity. This was a pioneering piece of work which has played a pivotal role in strengthening UK radiotherapy research, and was led by CTRad.” Prof. Neil Burnet, Chair in Clinical Academic Proton Therapy at The […]
We are pleased to announce the appointment of Dr Iain Frame as the new CEO of the NCRI.
Dr Frame will take over from Dr Karen Kennedy, who is leaving the role after more than four years at the helm.
Dr Frame is currently Director of Research at Prostate Cancer UK, an NCRI Partner organisation, and is an […]
Marker for aggressive prostate cancer doubles-up as a drug target
Researchers find key to drug resistant bowel cancer
One in six women diagnosed with breast cancer have a symptom other than a lump
Gold nanoparticles help deliver lethal one-two punch to cancer
Gut microbes linked to immunotherapy response in melanoma patients
Adult weight gain could increase cancer risk